CBS2017

丨Jul 06,2017

Paris, France - Starting from May 16, Left Main & Coronary Bifurcation Summit (CBS) will present the next congress plan at EuroPCR 2017 in Paris. An on-site platform for treatment against left main and coronary bifurcation lesions will be located on the third floor of the Palais des Congrès. All participants and cardiovascular experts are welcomed to CBS booth stand H9 during this 4-day meeting.

On the 10th Summit in this winter, CBS will continue the concept of patient-centric care. Discussion on the objectives like applying big data with well designed RCT to obtain more clinical evidence, incorporation of new interventional technologies and treatment options, integration of hemodynamic evaluation and mechanisms into the treatment, analysis and comparison of treatment options will be put on extra weight. CBS2017 will be helpful to make a comprehensive and in-depth academic exploration on the issue of left main and coronary bifurcation disease.

Upnext

DEFINITON Trial Released by EuroPCR 2020

Multicentre, Randomized Trial Comfirms Two-stent Approach Improves Clinical Outcomes Compared with Pro...

　... Read the full text

NEWS丨CBSMD

CBSMD丨Jun 28,2020

Upnext

SCAI 2020 - Invitation to Scientific Sessions

The Intersection of Innovation and Practice.

　... Read the full text

NEWS丨CBSMD

CBSMD丨May 14,2020